The Changing Vitiligo Treatment Landscape
Dr. Amit G. Pandya discusses study results for recently approved ruxolitinib cream for vitiligo and what researchers are reporting on investigational oral JAK inhibitors for vitiligo on the face and body. Amit G. Pandya, MD, Director, Pigmentary Disorders Clinic, Palo Alto Foundation Medical Group, Sunnyvale, California; and Adjunct Professor of Dermatology, University of Texas Southwestern […]